Concepedia

Publication | Open Access

CHA 2 DS 2 -VASc Scores and Major Bleeding in Patients With Nonvalvular Atrial Fibrillation Who Are Receiving Rivaroxaban

15

Citations

24

References

2016

Year

Abstract

Higher CHA<sub>2</sub>DS<sub>2</sub>-VASc scores are associated with increased incidence of major bleeding in nonvalvular atrial fibrillation patients receiving rivaroxaban.

References

YearCitations

Page 1